Home Research Series
Strategies ECM & IPO Index Rebalance Event-Driven Equity Bottom-Up Thematic Markets Greater China Other APAC US
About Team Contact Us
ECM

Impact Therapeutics (英派药业) IPO Trading

14 May 2026 By Ke Yan, CFA, FRM
← All Research ReportsMore ECM coverage →

Abstract: Impact Therapeutics raised HKD 759m (USD 97m) from its global offering and will list on the Hong Kong Stock Exchange on Friday, May 15th, 2026. In our previous note, we looked at the company's fundamentals and the valuation. In this note, we provide an update for the IPO before its trading debut.

GENFLEET (2595 HK) LEADS BIOLABS (9887 HK) IMPACT THERAP (7630 HK)

Highlighted Stocks

GENFLEET, LEADS BIOLABS, IMPACT THERAP

About IPO Trading

Notes on the trading dynamics before debut for newly listed Hong Kong shares. All issues of IPO Trading →

Related Reports

More from IPO Trading

Interested in the full report? Get in touch with our team.

Request Full Report

We will review your request. Once approved, the report will be sent to your company email.

Report: Impact Therapeutics (英派药业) IPO Trading
Date: 14 May 2026

Request Received!

Thank you! We will review your request and email the report to you, usually within 1 business day.